ADGM
Adagio Medical Holdings, Inc Common StockNASDAQHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$23.32M
P/E Ratio
—
EPS
$-1.51
Beta
0.04
52W High
$2.58
52W Low
$0.74
50-Day MA
$1.18
200-Day MA
$1.25
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Adagio Medical Holdings, Inc Common Stock
Adagio Medical Holdings, Inc. is a cutting-edge biotechnology company focused on developing advanced medical technologies for the treatment of cardiac arrhythmias. By leveraging its proprietary platform, Adagio is pioneering innovative targeted ablation techniques that fulfill significant gaps in the electrophysiology market. With a promising product pipeline and an experienced leadership team, the company offers a compelling investment opportunity for institutional investors seeking to participate in the rapidly evolving healthcare landscape and enhance patient care in the cardiac domain.
Fundamentals
| Revenue (TTM) | 137,000 |
| Gross Profit (TTM) | -684,000 |
| EBITDA | $-20.92M |
| Operating Margin | 0.00% |
| Return on Equity | -155.20% |
| Return on Assets | -29.80% |
| Revenue/Share (TTM) | $0.01 |
| Book Value | $0.56 |
| Price-to-Book | 1.84 |
| Price-to-Sales (TTM) | 205.85 |
| EV/Revenue | 370.25 |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 75.60% |
| Shares Outstanding | $22.21M |
| Float | $4.81M |
| % Insiders | 2.40% |
| % Institutions | 74.53% |
Historical Volatility
HV 10-Day
146.11%
HV 20-Day
160.58%
HV 30-Day
144.02%
HV 60-Day
103.78%
HV Rank
—
Volatility is currently expanding
Analyst Ratings
Consensus ($3.50 target)
1
BuyData last updated: 4/30/2026